Angers medical sprint scientific innovation board: annual revenue of RMB 300million and proposed fund raising of RMB 770million

RedI network Lei Jianping 6 month 27 Reported Wednesday

Hangzhou Angel Medical Technology Co., Ltd （ abbreviation ：“ Angel medicine ”） The prospectus was submitted a few days ago , Ready to be listed on the science and technology innovation board .

The angers medical program fundraising 7.7 One hundred million yuan , among ,2.93 100 million yuan per year 1000 10000 pieces of medical endoscope equipment and instruments ,1.12 Billion yuan will be used for the marketing service network upgrading construction project ,1.66 Billion yuan is used for the R & D center project of minimally invasive medical devices ,2 Billion yuan is used to supplement working capital .

Annual revenue 3 Billion

Angel medical is engaged in the research and development of endoscopic minimally invasive diagnostic and therapeutic instruments 、 Production and sales , The main products are used in the field of digestive endoscopy diagnosis and treatment , It can be divided into hemostatic closure according to its therapeutic use 、EMR/ESD class 、 Biopsy 、ERCP And diagnostic and therapeutic instruments . All kinds of minimally invasive diagnosis and treatment instruments produced by the company are used together with digestive endoscopes , The two complement each other , It can be used in the clinical diagnosis and treatment of digestive tract diseases .

The prospectus shows , Angel medicine 2019 year 、2020 year 、2021 The annual revenue is 1.83 One hundred million yuan 、1.72 One hundred million yuan 、3.05 One hundred million yuan ; The net profit is respectively 5473.95 Ten thousand yuan 、4523.44 Ten thousand yuan 、1.05 One hundred million yuan ; The net profit after deducting non profits is 5095 Ten thousand yuan 、3962 Ten thousand yuan 、1 One hundred million yuan .

Angers medicine is 2021 The annual dividend reached 5000 Ten thousand yuan .

Zhang Cheng is the actual controller

IPO front , The controlling shareholder of the company is Hangzhou Yijia Investment Management Co., Ltd ; The actual controller is Zhang Cheng .

Zhang Cheng directly owns the company 9.52% Shares of , And through holding Hangzhou Yijia Investment Management Co., Ltd 100% Equity of 、 Hangzhou Dingjie enterprise management partnership （ Limited partnership ）0.01% And as the managing partner 、 Ningbo Jiayi investment management partnership （ Limited partnership ）0.01% And as the managing partner , The proportion of shares with total disposable voting rights reaches 65.111%, Is the actual controller of the company .

Zhangqianyi, the limited partner of Ningbo Jiayi 、 Zhang Beijia is Zhang Cheng's daughter .

IPO after , Hangzhou Yijia shares 32.65%, Daan gene holds shares 10.37%, Zhang Cheng holds 7.14%, Ningbo Dingjie shares 5.74%, Suzhou Xinjian yuan holds shares of 5%, Paradise Silicon Valley Zhenghui holds shares of 4.5%, Guangzhou Da'an holds 4.47%, Ningbo Jiayi holds shares of 3.31%, Ningbo Daohe holds shares of 1.82%.

———————————————

Lei Di was founded by Lei Jianping, a senior media person , If reproduced, please indicate the source .